Literature DB >> 30556499

Cellular Senescence and Anti-Cancer Therapy.

Jieqiong You1, Rong Dong1, Meidan Ying1, Qiaojun He1, Ji Cao1, Bo Yang1.   

Abstract

BACKGROUND: Cellular senescence is generally understood as a permanent cell cycle arrest stemming from different causes. The mechanism of cellular senescence-induced cell cycle arrest is complex, involving interactions between telomere shortening, inflammations and cellular stresses. In recent years, a growing number of studies have revealed that cellular senescence could mediate the cancer progression of neighboring cells, but this idea is controversial and contradictory evidence argues that cellular senescence also contributes to tumor suppression.
OBJECTIVE: Given that the complicated role of senescence in various physiological and pathological scenarios, we try to clarify the precise contribution role of cellular senescence to tumor progression.
METHODS: Search for the information in a large array of relevant articles to support our opinion.
RESULTS: We discuss the relatively widespread occurrence of cellular senescence in cancer treatment and identify the positive and negative side of senescence contributed to tumor progression.
CONCLUSION: We argue that the availability of pro-senescence therapy could represent as a promising regimen for managing cancer disease, particularly with regard to the poor clinical outcome obtained with other anticancer therapies. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cellular senescence; biomarkers; cancer therapy; drug in combination; mechanism; tumor suppression.

Year:  2019        PMID: 30556499     DOI: 10.2174/1389450120666181217100833

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  5 in total

1.  Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma.

Authors:  Miguel Angel Merlos Rodrigo; Hana Michalkova; Vladislav Strmiska; Berta Casar; Piero Crespo; Vivian de Los Rios; J Ignacio Casal; Yazan Haddad; Roman Guran; Tomas Eckschlager; Petra Pokorna; Zbynek Heger; Vojtech Adam
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

2.  A protocol for rapid construction of senescent cells.

Authors:  Xing Yu; Jing Quan; Shuai Chen; Xinyue Yang; Shuai Huang; Gang Yang; Yujing Zhang
Journal:  Front Integr Neurosci       Date:  2022-07-29

3.  Construction of Molecular Subtype and Prognosis Prediction Model of Osteosarcoma Based on Aging-Related Genes.

Authors:  Chunli Dong; Yindi Sun; Ying Zhang; Bianni Qin; Tao Lei
Journal:  J Oncol       Date:  2022-09-16       Impact factor: 4.501

4.  Erdafitinib Inhibits Tumorigenesis of Human Lung Adenocarcinoma A549 by Inducing S-Phase Cell-Cycle Arrest as a CDK2 Inhibitor.

Authors:  Xinmin Meng; Xue Zhu; Jiali Ji; Hongqin Zhong; Xiyue Li; Hongqing Zhao; Guijuan Xie; Ke Wang; Hong Shu; Xun Wang
Journal:  Molecules       Date:  2022-10-09       Impact factor: 4.927

Review 5.  Fibronectin in Cancer: Friend or Foe.

Authors:  Tsung-Cheng Lin; Cheng-Han Yang; Li-Hsin Cheng; Wen-Tsan Chang; Yuh-Rong Lin; Hung-Chi Cheng
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.